Ft. Lauderdale, FL, United States of America

Vaughan Wittman


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Vaughan Wittman: Innovator in Peptide Synthesis

Introduction

Vaughan Wittman is a notable inventor based in Ft. Lauderdale, FL (US). He has made significant contributions to the field of peptide synthesis and purification, holding a total of 2 patents. His work focuses on innovative methods that enhance the efficiency and effectiveness of peptide production.

Latest Patents

Wittman's latest patents include groundbreaking techniques for peptide synthesis and purification. One of his inventions, titled "Peptide synthesis and purification by fusion to penI protein," provides novel methods for the synthesis, isolation, and purification of target peptides. This invention utilizes penI fusion polypeptides and related gene fusion constructs to streamline the peptide production process. Another patent, also focused on methods for peptide synthesis and purification, emphasizes similar innovative approaches to enhance the efficiency of peptide isolation.

Career Highlights

Vaughan Wittman has established himself as a key figure in the biotechnology sector. He is currently associated with Dade International Inc., where he continues to develop and refine his innovative techniques in peptide synthesis. His work has garnered attention for its potential applications in various fields, including pharmaceuticals and biotechnology.

Collaborations

Wittman collaborates with talented individuals in his field, including Rony Tal and Hing C Wong. These partnerships contribute to the advancement of his research and the successful implementation of his patented methods.

Conclusion

Vaughan Wittman is a distinguished inventor whose work in peptide synthesis and purification has the potential to revolutionize the industry. His innovative patents and collaborations highlight his commitment to advancing biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…